R. Kinas

发表

Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans.

W. Stec, J. Smyth, M. Jarman, 1979, Cancer research.

Studies on the side-chain hydroxylation of ifosfamide and its bromo analogue.

K. Misiura, R. Kinas, H. Kuśnierczyk, 2002, Bioorganic & medicinal chemistry letters.

Stereochemistry of hydrolysis of adenosine 3':5'-cyclic phosphorothioate by the cyclic phosphodiesterase from beef heart.

W. Stec, F. Eckstein, P. Burgers, 1979, The Journal of biological chemistry.

Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits.

W. Stec, P. Farmer, P. Cox, 1978, Drug metabolism and disposition: the biological fate of chemicals.

Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.

W. Stec, K. Misiura, R. Kinas, 1988, Journal of medicinal chemistry.

Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.

W. Stec, K. Misiura, R. Kinas, 1986, Journal of immunopharmacology.

Effects of alkylating metabolites of ifosfamide and its bromo analogues on DNA of HeLa cells.

L. Szmigiero, R. Kinas, K. Studzian, 1992, Biochemical pharmacology.

(S)-(−)-Bromofosfamide (CBM-11): synthesis and antitumor activity and toxicity in mice

W. Stec, K. Misiura, R. Kinas, 2001, Anti-cancer drugs.

Pharmacokinetic-stereoselective differentiation of some isomeric analogues of ifosfamide.

A. Sloderbach, B. Hładoń, R. Kinas, 1997, Polish journal of pharmacology.

Application of deuterium labelling mass spectrometry in a study of the metabolism of the enantiomers of cyclophosphamide.

W. Stec, P. Farmer, P. Cox, 1977, Biomedical mass spectrometry.